Clinical Trial: Induction Chemotherapy Response-Adapted Stereotactic Body Radiotherapy and Immunotherapy in HPV-Associated Oropharyngeal Carcinoma (China)

China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Induction Chemotherapy Response-Adapted Stereotactic Body Radiotherapy and Immunotherapy in HPV-Associated Oropharyngeal Carcinoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133542

Registration Time: 2026/09/29

Type: Interventional study

Primary Sponsor: Fudan University Shanghai Cancer Center

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339888

Published by HT Digital Content Services with permission from Health Daily Digest....